Chemiluminescence analysis of drug resistance of the recombinant tissue plasminogen activator

Simple item page
dc.contributor.authorBatyuk, Liliya
dc.contributor.authorMuraveinik, Oksana
dc.contributor.authorKizilova, Nataliya
dc.date.accessioned2021-06-16T17:15:02Z
dc.date.available2021-06-16T17:15:02Z
dc.date.issued2021-05-20
dc.description.abstractThe aim of this work was to study the biochemiluminescence of blood serum and whole blood in patients who were prescribed rtPA (at a dose of 0.9 mg/kg, the maximum dose was 90 mg) during the first 3 hours after the onset of neurological symptoms (onset of IS).en_US
dc.identifier.citationChemiluminescence analysis of drug resistance of the recombinant tissue plasminogen activator / L. V. Batyuk, O. A. Muraveinik, N. N. Kizilova // Современные проблемы клеточной инженерии, иммунологии и аллергологии : международная научная конференция, Минск, 20–21 мая 2021 : сборник тезисов / Институт биофизики и клеточной инженерии НАН Беларуси. – Беларусь, 2021. – С. 58.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/28966
dc.language.isoen_USen_US
dc.publisherИнститут биофизики и клеточной инженерии НАН Беларусиen_US
dc.subjectischemic strokeen_US
dc.subjectallergic reactionsen_US
dc.subjectreperfusion therapyen_US
dc.subjectchemiluminescenceen_US
dc.titleChemiluminescence analysis of drug resistance of the recombinant tissue plasminogen activatoren_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Chemiluminescence analysis of drug resistance of the recombinant tissue plasminogen activator .pdf
Size:
276.62 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
11.22 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Наукові праці. Кафедра медичної та біологічної фізики і медичної інформатики